Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20,907,188
-
Total 13F shares
-
7,555,380
-
Share change
-
+7,538,447
-
Total reported value
-
$168,332,336
-
Put/Call ratio
-
2.8%
-
Price per share
-
$22.28
-
Number of holders
-
57
-
Value change
-
+$167,955,068
-
Number of buys
-
56
Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q4 2023
As of 31 Dec 2023 Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,555,380 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Verition Fund Management LLC, Point72 Asset Management, L.P., PFM Health Sciences, LP, Cormorant Asset Management, LP, VANGUARD GROUP INC, VR Adviser, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Velan Capital Investment Management LP, and ACUTA CAPITAL PARTNERS, LLC.
This table shows 57 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.